For those concerned with eliminating cervical cancer, the effects of the COVID-19 response are extremely concerning. Challenges include reduced or delayed screening; the issue plummeting down governments’ agenda; and scarce supplies of the HPV vaccine. Professor Singer outlines the impact of these changes and offers two limited solutions that may help keep our battle against cervical cancer on track.
For those concerned with eliminating cervical cancer, the effects of the COVID-19 response are extremely concerning. Challenges include reduced or delayed screening; the issue plummeting down governments’ agenda; and scarce supplies of the HPV vaccine. Professor Singer outlines the impact of these changes and offers two limited solutions that may help keep our battle against cervical cancer on track.
